nivolumab,ipilimumab
bms
[]
again , new promising data for lynch patients in neoadjuvant setting. immunotheray acces via imhotep trial
#esmo2022 
French onco med . looking with interest : genetic counseling/ intratumoral immunotherapy/supportive care